Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, has received $11.5m in Series A equity financing round, led by new and existing investors. Kala said ...
Regeneron Pharmaceuticals and Bayer HealthCare have started a new Phase 3 VEGF Trap-Eye In Vision Impairment Due to DME (VIVID EAST-DME) trial of its Eylea (aflibercept) injection. Eylea, which is formulated as an iso-osmotic solution for ...
A new study has looked at how certain gene variants may predict whether an individual is likely to develop age-related macular degeneration (AMD). This eye disease affects over nine million Americans, but it has been found that certain ...
Lonza has received a contract from Intellect Neurosciences to develop and manufacture the antibody drug conjugate, Conjumab-A. Under the contract, Lonza will supply the preclinical study material for the drug optimization and drug ...
Tags: Lonza, antibody drug, Neurosciences, antibody drug conjugate
The European Commission (EC) has approved Bayer HealthCare's EYLEA (aflibercept solution for injection) at a recommended dose of 2 mg for the treatment of wet age-related macular degeneration (wet AMD). Formulated as an iso-osmotic ...
Tags: European Commission, Bayer, Aflibercept Solution, EYLEA
Allergan and Molecular Partners have expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products to treat ophthalmic diseases. The first ...
Regeneron Pharmaceuticals has received Japanese Ministry of Health,Labour and Welfare(MHLW)approval for its Eylea(aflibercept)injection to treat patients with neovascular age-related macular degeneration(wet AMD)symptoms. Regeneron chief ...
Tags: Regeneron Pharmaceuticals, Eylea Injection, wet AMD, George Yancopoulos
Lighting LEDs are a route to energy efficiency that also allow creative effects that were not possible with incandescent bulbs and fluorescent tubes. But the output spectrum, like that of fluorescent tubes, is nothing like the sunlight ...
Tags: LED lighting, LED, Lighting LEDs, energy efficiency, energy
Genentech, a member of Roche Group, has obtained clearance for its Lucentis 0.3 mg (ranibizumab injection) from the US Food and Drug Administration (FDA). Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an ...
Tags: Genentech, Lucentis 0.3 mg, Medicine, Injection
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin has signed a co-promotion agreement with Santen Pharmaceutical for Eylea (aflibercept) injection in Japan. Eylea is approved for sale in the US and Australia for the treatment of ...
Stanford retinal implant combats vision loss 21 May 2012 An implanted subretinal array could restore useful sight to patients blinded by degenerative retinal diseases. A simpler system One characteristic of retinal conditions such as ...